Sponsor
                    Cedars-Sinai Medical Center
                Status
                    Recruiting
                NCT ID
                    NCT05347342
                To improve upon the non-invasive detection of bladder cancer by further validating a multiplex ELISA assay directed at a bladder cancer-associated diagnostic signature in voided urine samples of patients with a high risk of developing bladder cancer.
            
  
  
      Condition
                    Bladder Cancer
                Investigators
                    Hideki Furuya, Charles J Rosser, MD, MBA, Greg Gin, MD
                